Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class, used as a high-purity active pharmaceutical ingredient (API) in the production of medications for pain and inflammation management. It treats conditions including osteoarthritis, rheumatoid arthritis, postoperative pain, dental pain, and acute/chronic musculoskeletal disorders.

Mechanism: Potently inhibits cyclooxygenase (COX-1/COX-2) enzymes, reducing prostaglandin production to alleviate pain and swelling. Known for rapid onset, ideal for short-term use.

Product specifications: Yellow crystalline powder; Assay: 98.5-100% (typically 99%); Particle size: 40 μm. Monitor for potential GI/cardiovascular risks in formulated products; use under medical guidance.